In vitro antimicrobial activity of narasin and monensin in combination with adjuvants against pathogens associated with canine otitis externa

Veterinary Dermatology
Wei Yee ChanPeter B Hill

Abstract

The emergence of antimicrobial resistance represents a serious human and animal health risk. Good antimicrobial stewardship is essential to prolong the lifespan of existing antibiotics, and new strategies are required to combat infections in man and animals. To determine the in vitro interaction of ionophores (narasin or monensin) with antimicrobial adjuvants (N-acetylcysteine (NAC), Tris-EDTA or disodium EDTA) against bacterial strains representing pathogens associated with canine otitis externa (OE). American Type Culture Collection (ATCC) strains Staphylococcus aureus 29213, Pseudomonas aeruginosa 27853 and P. aeruginosa biofilm producer PAO1, and a clinical isolate of Proteus mirabilis from a case of canine OE were tested. A 2D microdilution checkerboard method was used, allowing calculation of fractional inhibitory concentration index (FICI), dose reduction index (DRI) and plotting of isobolograms. The combination of narasin with either Tris-EDTA or disodium EDTA produced additive effects (FICI = 0.75) against P. aeruginosa ATCC 27853 and P. aeruginosa biofilm producer ATCC PAO1. An additive effect (FICI = 0.53-0.75) was found against S. aureus ATCC 29213 when narasin or monensin were combined with NAC. The highest DRI (32...Continue Reading

References

Jun 1, 1965·Journal of General Microbiology·G W Gray, S G Wilkinson
Jun 1, 1967·Journal of General Microbiology·M C Goldschmidt, O Wyss
Dec 1, 1984·Veterinary Microbiology·R E WooleyE B Shotts
Apr 1, 1995·Natural Product Reports·C J DuttonC B Cooper
Jan 16, 2004·Journal of Applied Microbiology·R J W LambertS P Denyer
May 4, 2006·The Journal of Pharmacology and Experimental Therapeutics·Ronald J Tallarida
Nov 3, 2007·Journal of the American Animal Hospital Association·Brett Everett WildermuthMona J Boord
Nov 23, 2013·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Razan HamoudMichael Wink
Jan 18, 2014·Learning & Memory·Irina FilonovaEdwin J Weeber
Feb 28, 2015·The Veterinary Clinics of North America. Small Animal Practice·Luca Guardabassi, John F Prescott
Feb 18, 2016·International Forum of Allergy & Rhinology·Edward C KuanJeffrey D Suh
Apr 12, 2016·Journal of Environmental Quality·Murugan SubbiahDouglas R Call
Jun 1, 2016·Diagnostic Microbiology and Infectious Disease·R SomayajiD Church
Sep 19, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Ana Catarina RodriguesConstança Pomba
Jul 19, 2018·Comparative Immunology, Microbiology and Infectious Diseases·Wei Yee ChanPeter B Hill

Related Concepts

Acetylcysteine
Antibiotics
Edetic Acid, Disodium Salt
Canis familiaris
Gram-Negative Bacteria
Ionophores
Male Population Group
Monensin
Otitis Externa
Proteus mirabilis

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.